Published on
March 12, 2018
- 00:00 GMT
Arcturus Therapeutics Announces Extraordinary General Meeting of Shareholders
Board of Directors Recommends Removal of Terminated CEO Joseph Payne from Board of Directors SAN DIEGO, March 11, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (Arcturus or the Company) (NASDAQ:ARCT), an RNA medicines company, today announced that it …
Distribution channels:
Healthcare & Pharmaceuticals Industry
...
